210 related articles for article (PubMed ID: 23100110)
1. HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.
Rothman MS; Bessesen MT
Curr Osteoporos Rep; 2012 Dec; 10(4):270-7. PubMed ID: 23100110
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Biver E; Calmy A; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Ferrari S; Frey D; Kressig RW; Lamy O; Lippuner K; Suhm N; Meier C
Osteoporos Int; 2019 May; 30(5):1125-1135. PubMed ID: 30603840
[TBL] [Abstract][Full Text] [Related]
3. Bone disease in the setting of HIV infection: update and review of the literature.
Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
[TBL] [Abstract][Full Text] [Related]
4. Management of glucocorticoid-induced osteoporosis: What is new?
Compston J
Int J Rheum Dis; 2019 Sep; 22(9):1595-1597. PubMed ID: 31478605
[No Abstract] [Full Text] [Related]
5. HIV and bone loss.
Arora S; Agrawal M; Sun L; Duffoo F; Zaidi M; Iqbal J
Curr Osteoporos Rep; 2010 Dec; 8(4):219-26. PubMed ID: 20830538
[TBL] [Abstract][Full Text] [Related]
6. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Treatment of Osteoporosis.
O'Connor KM
Med Clin North Am; 2016 Jul; 100(4):807-26. PubMed ID: 27235616
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of bone fragility in diabetes: an emerging challenge.
Ferrari SL; Abrahamsen B; Napoli N; Akesson K; Chandran M; Eastell R; El-Hajj Fuleihan G; Josse R; Kendler DL; Kraenzlin M; Suzuki A; Pierroz DD; Schwartz AV; Leslie WD;
Osteoporos Int; 2018 Dec; 29(12):2585-2596. PubMed ID: 30066131
[TBL] [Abstract][Full Text] [Related]
9. Disparities in osteoporosis treatments.
Liu Z; Weaver J; de Papp A; Li Z; Martin J; Allen K; Hui S; Imel EA
Osteoporos Int; 2016 Feb; 27(2):509-19. PubMed ID: 26216226
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis and HIV.
O'Connor MB
Ir J Med Sci; 2013 Dec; 182(4):747-8. PubMed ID: 23588816
[No Abstract] [Full Text] [Related]
11. Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
Beaton DE; Vidmar M; Pitzul KB; Sujic R; Rotondi NK; Bogoch ER; Sale JEM; Jain R; Weldon J
Osteoporos Int; 2017 Mar; 28(3):863-869. PubMed ID: 27770155
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of osteoporosis in older adults.
Diab DL; Watts NB
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):305-17. PubMed ID: 23702403
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis and bone health in HIV.
Powderly WG
Curr HIV/AIDS Rep; 2012 Sep; 9(3):218-22. PubMed ID: 22581359
[TBL] [Abstract][Full Text] [Related]
14. We miss the opportunity: Pretreament of osteoporosis in a German trauma center.
Rausch V; Schwarzer A; Dietrich JW; Kaisler M; Seybold D; Vollert J; Schildhauer TA; Maier C
PLoS One; 2018; 13(11):e0207122. PubMed ID: 30418992
[TBL] [Abstract][Full Text] [Related]
15. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis management among chronic glucocorticoid users: a systematic review.
Albaum JM; Youn S; Levesque LE; Gershon AS; Cadarette SM
J Popul Ther Clin Pharmacol; 2014; 21(3):e486-504. PubMed ID: 25527817
[TBL] [Abstract][Full Text] [Related]
17. [Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy].
Jakob F; Seefried L; Schwab M
Internist (Berl); 2014 Jul; 55(7):755-61. PubMed ID: 24903137
[TBL] [Abstract][Full Text] [Related]
18. Drugs for the treatment of metabolic bone diseases.
Drake MT; Cremers S; Russell RG; Bilezikian JP
Br J Clin Pharmacol; 2019 Jun; 85(6):1049-1051. PubMed ID: 30950086
[No Abstract] [Full Text] [Related]
19. A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving.
Leslie WD; Giangregorio LM; Yogendran M; Azimaee M; Morin S; Metge C; Caetano P; Lix LM
Osteoporos Int; 2012 May; 23(5):1623-9. PubMed ID: 21476038
[TBL] [Abstract][Full Text] [Related]
20. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
